TSC1 and urinary system disorder: After comparing multiple clinical phenotypes in individuals with different TSC1/TSC2 mutation types, we found no significant differences in CNS, cutaneous manifestations, cardiac rhabdomyoma, renal system disorders, or TAND (Table 3).